253 related articles for article (PubMed ID: 17296704)
1. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.
Kamel IR; Reyes DK; Liapi E; Bluemke DA; Geschwind JF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):49-56. PubMed ID: 17296704
[TBL] [Abstract][Full Text] [Related]
2. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
3. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
[TBL] [Abstract][Full Text] [Related]
4. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
[TBL] [Abstract][Full Text] [Related]
5. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.
Vossen JA; Kamel IR; Buijs M; Liapi E; Georgiades CS; Hong K; Geschwind JF
J Comput Assist Tomogr; 2008; 32(3):347-52. PubMed ID: 18520535
[TBL] [Abstract][Full Text] [Related]
6. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization.
Deng J; Miller FH; Rhee TK; Sato KT; Mulcahy MF; Kulik LM; Salem R; Omary RA; Larson AC
J Vasc Interv Radiol; 2006 Jul; 17(7):1195-200. PubMed ID: 16868174
[TBL] [Abstract][Full Text] [Related]
8. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
Salem R; Lewandowski RJ; Atassi B; Gordon SC; Gates VL; Barakat O; Sergie Z; Wong CY; Thurston KG
J Vasc Interv Radiol; 2005 Dec; 16(12):1627-39. PubMed ID: 16371529
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
Sahin H; Harman M; Cinar C; Bozkaya H; Parildar M; Elmas N
J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
[TBL] [Abstract][Full Text] [Related]
10. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS
J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765
[TBL] [Abstract][Full Text] [Related]
11. Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma.
Fleming CJ; Andrews JC; Wiseman GA; Gansen DN; Roberts LR
J Vasc Interv Radiol; 2009 Nov; 20(11):1460-3. PubMed ID: 19875064
[TBL] [Abstract][Full Text] [Related]
12. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
Gaba RC; Lewandowski RJ; Kulik LM; Riaz A; Ibrahim SM; Mulcahy MF; Ryu RK; Sato KT; Gates V; Abecassis MM; Omary RA; Baker TB; Salem R
Ann Surg Oncol; 2009 Jun; 16(6):1587-96. PubMed ID: 19357924
[TBL] [Abstract][Full Text] [Related]
13. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
[TBL] [Abstract][Full Text] [Related]
14. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation.
Kulik LM; Atassi B; van Holsbeeck L; Souman T; Lewandowski RJ; Mulcahy MF; Hunter RD; Nemcek AA; Abecassis MM; Haines KG; Salem R
J Surg Oncol; 2006 Dec; 94(7):572-86. PubMed ID: 17048240
[TBL] [Abstract][Full Text] [Related]
15. Biliary sequelae following radioembolization with Yttrium-90 microspheres.
Atassi B; Bangash AK; Lewandowski RJ; Ibrahim S; Kulik L; Mulcahy MF; Murthy R; Ryu RK; Sato KT; Miller FH; Omary RA; Salem R
J Vasc Interv Radiol; 2008 May; 19(5):691-7. PubMed ID: 18440457
[TBL] [Abstract][Full Text] [Related]
16. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
IƱarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B
J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574
[TBL] [Abstract][Full Text] [Related]
17. Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments.
Ibrahim SM; Lewandowski RJ; Ryu RK; Sato KT; Gates VL; Mulcahy MF; Kulik L; Larson AC; Omary RA; Salem R
Cardiovasc Intervent Radiol; 2008; 31(6):1124-32. PubMed ID: 18509704
[TBL] [Abstract][Full Text] [Related]
18. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
Lewandowski RJ; Riaz A; Ryu RK; Mulcahy MF; Sato KT; Kulik LM; Gates VL; Baker T; Omary R; Salem R
J Vasc Interv Radiol; 2009 Dec; 20(12):1557-63. PubMed ID: 19854068
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.
Kanematsu M; Semelka RC; Leonardou P; Mastropasqua M; Lee JK
J Magn Reson Imaging; 2003 Aug; 18(2):189-95. PubMed ID: 12884331
[TBL] [Abstract][Full Text] [Related]
20. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Salem R; Lewandowski RJ; Mulcahy MF; Riaz A; Ryu RK; Ibrahim S; Atassi B; Baker T; Gates V; Miller FH; Sato KT; Wang E; Gupta R; Benson AB; Newman SB; Omary RA; Abecassis M; Kulik L
Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]